traitement
| 1 |
en centre |
HD |
1516 |
| 2 |
en UDM |
HD |
115 |
| 3 |
en autodialyse |
HD |
53 |
| 5 |
en entrainement |
HD |
209 |
| 6 |
DPCA à domicile |
DP |
128 |
| 7 |
DPA à domicile |
DP |
84 |
| 8 |
en entrainement |
DP |
77 |
analyse bivariée décès post AVC
|
AVC(+) |
AVC(-) |
AVC(-) |
AVC(+) |
|
(n=35) |
(n=1926) |
(n=203) |
(n=18) |
| tabagisme |
|
|
|
|
| non |
18 (60.0) |
1049 (62.3) |
100 (62.1) |
10 (66.7) |
| oui |
12 (40.0) |
635 (37.7) |
61 (37.9) |
5 (33.3) |
| sex |
|
|
|
|
| homme |
20 (57.1) |
995 (51.7) |
115 (56.7) |
14 (77.8) |
| femme |
15 (42.9) |
931 (48.3) |
88 (43.3) |
4 (22.2) |
| age moyen * |
64.36 (11.98) |
58.04 (12.03) |
73.25 (12.08) |
64.10 (11.35) |
| diagnostic * |
|
|
|
|
| aucun événement |
0 (0.0) |
1923 (99.8) |
202 (99.5) |
0 (0.0) |
| AIT |
11 (31.4) |
1 (0.1) |
0 (0.0) |
4 (22.2) |
| hémorragie sous-arachnoïdienne |
3 (8.6) |
0 (0.0) |
0 (0.0) |
1 (5.6) |
| hémorragie intracérébrale |
7 (20.0) |
1 (0.1) |
0 (0.0) |
8 (44.4) |
| infarctus cérébral |
13 (37.1) |
1 (0.1) |
1 (0.5) |
5 (27.8) |
| AVC (ischémique ou hémorragique) |
1 (2.9) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
| traitement |
|
|
|
|
| anticoag |
10 (45.5) |
465 (51.3) |
54 (48.6) |
4 (36.4) |
| antiplaq |
12 (54.5) |
441 (48.7) |
57 (51.4) |
7 (63.5) |
| DM ou pas de traitement |
13 |
1020 |
92 |
7 |
| type de dialyse |
|
|
|
|
| DP |
7 (20.0) |
225 (13.2) |
25 (12.3) |
2 (11.1) |
| HD |
28 (80.0) |
1671 (868) |
178 (87.7) |
16 (88.9) |
| atcd * |
|
|
|
|
| non |
27 (77.1) |
1797 (93.3) |
187 (92.1) |
16 (88.9) |
| oui |
8 (22.9) |
129 (6.7) |
16 (7.9) |
2 (11.1) |
| cause décès |
|
|
|
|
| non décédé/inconnue |
35 (100.0) |
1926 (100.0) |
13 (6.4) |
2 (11.1) |
| I |
0 (0.0) |
0 (0.0) |
39 (19.2) |
7 (38.9) |
| III |
0 (0.0) |
0 (0.0) |
21 (10.3) |
1 (5.6) |
| V |
0 (0.0) |
0 (0.0) |
31 (15.3) |
1 (5.6) |
| VI |
0 (0.0) |
0 (0.0) |
99 (48.8) |
7 (38.9) |
| transplantation * |
|
|
|
|
| non |
24 (68.6) |
1055 (54.8) |
184 (90.6) |
16 (88.9) |
| oui |
11 (31.4) |
871 (45.2) |
19 (9.4) |
2 (11.1) |
| atcd cardiovasc * |
|
|
|
|
| non |
18 (52.9) |
1409 (76.5) |
92 (48.4) |
8 (53.3) |
| oui |
16 (47.1) |
434 (23.5) |
98 (51.6) |
7 (46.7) |
| diabetes * |
|
|
|
|
| non |
32 (91.4) |
1754 (91.4) |
172 (84.7) |
17 (94.4) |
| oui |
3 (8.6) |
165 (8.6) |
31 (15.3) |
1 (5.6) |
| IMC * |
|
|
|
|
| <18.5 |
0 (0.0) |
47 (2.7) |
10 (5.4) |
1 (7.7) |
| [18.5-25[ |
24 (75.0) |
764 (44.6) |
88 (47.6) |
3 (23.1) |
| [25-30[ |
5 (15.6) |
574 (33.5) |
67 (36.2) |
6 (46.2) |
| ≥30 |
3 (9.4) |
328 (19.1) |
20 (10.8) |
3 (23.1) |
| temps moyen de FUP (en jours) * |
1029.91 (539.54) |
862.73 (484.61) |
601.65 (456.59) |
750.22 (476.34) |
délai au décès
| min-max |
1.0-1470.0 |
3.0-1251.0 |
| médiane [25 - 75%] |
336.0 [129.5 - 617] |
726.5 [365.2 - 1093.2] |
| moyenne (ET) |
465.07 (426.41) |
750.2 (476.3) |
(*) p-value (WMW) = 0.01811
transplantation
|
|
|
|
| total, n (%) |
1279 (58.6) |
903 (41.4) |
|
| event, n (%) |
|
|
0.01 |
| E(-) |
1279 (96.9) |
890 (98.6) |
|
| E(+) |
40 (3.1) |
13 (1.4) |
|
| death, n (%) |
|
|
<0.001 |
| D(-) |
1079 (84.4) |
882 (97.7) |
|
| D(+) |
200 (15.6) |
21 (2.3) |
|
follow-up après transplantation
|
n = 21 |
n = 13 |
| min-max |
31.0-583.0 |
25.0-1275.0 |
| médiane [25-75%] |
153.0 [144 - 175.0] |
541.0 [302.0 - 840.0] |
| moyenne (ET) |
217.2 (306.4) |
585 (408.0) |
transplantation et antécédent d’événement
| pas d’atécédent |
1180 |
847 |
| antécédent |
99 |
56 |